Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Preservation of Women's Fertility: Evaluation of Innovative Methods for Ovarian Tissue Cryopreservation

A legfontosabb adatok

Ki végzi
University Hospital, Clermont-Ferrand
Hol
Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
30 fő vett részt
Kezdés
2022. máj. 5.
Befejezés
2025. dec. 31.
A vizsgálat típusa
Megfigyeléses, 3 csoport
A vizsgált kezelések
  • Human ovarian tissue cryopreservation using thermosoldered or screwed cryovials
A regiszteradat frissítve
2025. június 29.

Ki vehet részt

Életkor
18 év – 37 év
Nem
Csak nők
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 9 feltétel megnézéseKevesebb

Ki vehet részt

  • Adult woman scheduled for benign ovarian cyst resection (dermoid, functional, mucinous or serous cysts)
  • Below 37 years old and above 18 years old
  • Capable of giving written informed consent to participate in the research study
  • Affiliated to social welfare service

Ki nem vehet részt

  • Polycystic ovary syndrome
  • Malignant and endometrial cysts
  • Women above 37 years old and below 18 years old
  • Diminished ovarian reserve
  • Severe endometriosis

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The recent innovations in cancer diagnosis and therapy have improved the five-year survival for patients. However, anticancer treatments may impair patient fertility; therefore fertility preservation is recommended before therapy initiation. The sole method for preserving young prepubescent girls' fertility, which can also be used for pubescent women, is ovarian tissue cryopreservation (OTC) with later auto-transplantation. Although 200 births have been reported worldwide after OTC and transplantation, significant improvements are required. Indeed, freezing and thawing protocols vary according to laboratories (media, cryoprotectants, freezing curve, etc…) and selection criteria are not justified. In addition, most of the laboratories use unsafe devices (e.g. screw cap cryovials) for OTC, exposing ovarian tissues to biological hazards during sample storage in nitrogen tanks. To eliminate these risks, novel "high security" devices have been commercialized (welded cryotubes). However, while thermal welding could alter tissue quality, the functionality of the human ovarian tissue frozen with these innovative devices has not yet been evaluated. The objectives of this study are i) to optimize the freezing and the thawing protocols for human OTC according to thermodynamic properties of the freezing medium and the type of device (welded or screwed cryotube) and ii) to determine if the type of cryotube influences the quality of human ovarian tissue.

A teljes eredeti leírásKevesebb

This project will enable to reach a better understanding of the impact of freezing on ovarian tissue functionality, as well as the implementation of an optimal protocol for OTC within the ART laboratory of Clermont-Ferrand hospital to optimize patient care.

A vizsgálat 3 csoportja

  • Fresh ovarian cortex fragments

    Pericystic ovarian cortex will be cut into 1mm3 fragments and either directly analyzed on the day of collection (D0) or after organotypic culture (D7 and D14).

  • Fragments of ovarian cortex frozen in thermosoldered cryovials.

    Pericystic ovarian cortex will be cut into 1mm3 fragments, frozen using a slow programmable freezing device (Nano Digitcool, Cryo Bio System) in thermosoldered cryovials and stored in liquid nitrogen (-196°C). Then, fragments will be thawed before being analyzed on the day of thawing (D'0) and after 7 and 14 days (D7 and D14) of organotypic culture.

    Kezelés: Human ovarian tissue cryopreservation using thermosoldered or screwed cryovials

  • Fragments of ovarian cortex frozen in screwed cryovials.

    Pericystic ovarian cortex will be cut into 1mm3 fragments, frozen using a slow programmable freezing device (Nano Digitcool, Cryo Bio System) in screwed cryovials and stored in liquid nitrogen (-196°C). Then fragments will be thawed before being analyzed on the day of thawing (D'0) and after 7 and 14 days (D7 and D14) of organotypic culture.

    Kezelés: Human ovarian tissue cryopreservation using thermosoldered or screwed cryovials

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2025. június 29.